ABP
Abpro Corporation
NASDAQ · Healthcare · Biotechnology · US
$0.52
+0.00%Margins
Gross margin
-55.2%
EBITDA margin
-6649.2%
EBIT margin
-7950.8%
Net margin
-7670.5%
FCF margin
-7453.6%
86.9%
Return on equity
-824.3%
Return on assets
91.0%
Return on invested capital
0.07x
Asset turnover
-$13.6M
Cash from operations
$0.13
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2025